Cross-source evidence timeline

Teduglutide research timeline

Follow 58 selected, directly cited source records from May 7, 2012 through September 8, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.

58Selected records
12Source years
3Evidence lanes
September 8, 2026Latest source date

Source year

2026

6 records
  1. Clinical trials

    ClinicalTrials.gov record NCT06973304↗

    PeptideScanner retained ClinicalTrials.gov record NCT06973304 at 2026-11-15T21:55:23.600Z. Its registry update date was 2026-09-08, and PeptideScanner's reviewed identity mapping was teduglutide.↗

  2. Literature metadata

    Real-life experience of teduglutide use in pediatric patients with short bowel syndrome in Argentina. A multicenter study.↗

    PubMed lists PMID 41647102 in Intestinal Failure (New York, N.Y.) as Journal Article, with publication-date metadata of 2024-11-28 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Literature metadata

    Teduglutide in pediatric intestinal failure: A position statement of the Italian society of pediatric gastroenterology, hepatology and nutrition (SIGENP).↗

    PubMed lists PMID 35654733 in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver as Journal Article, Review, Consensus Statement, with publication-date metadata of 2022-05-31 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  4. Literature metadata

    Use of teduglutide for short bowel syndrome and Crohn's disease in a patient treated with ustekinumab and vedolizumab dual biologic therapy.↗

    PubMed lists PMID 36177820 in Revista espanola de enfermedades digestivas as Case Reports, Journal Article, with publication-date metadata of 2023-06 (month precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  5. Literature metadata

    Short-term clinical evaluation of teduglutide for patients with Crohn's disease on home parenteral support for postoperative short bowel syndrome with intestinal failure.↗

    PubMed lists PMID 37001195 in Clinical nutrition (Edinburgh, Scotland) as Journal Article, with publication-date metadata of 2023-03-18 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  6. Literature metadata

    Unexpected upper gastrointestinal polyps in patients with short bowel syndrome treated with teduglutide: need for close monitoring.↗

    PubMed lists PMID 37270288 in The American journal of clinical nutrition as Journal Article, with publication-date metadata of 2023-05-03 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2025

6 records
  1. Literature metadata

    Quality of life and lived experience of patients with short bowel syndrome treated with teduglutide and weaning off home parenteral nutrition: a qualitative analysis of patient diaries.↗

    PubMed lists PMID 40764045 in BMJ open gastroenterology as Journal Article, with publication-date metadata of 2025-08-05 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT03562130↗

    PeptideScanner retained ClinicalTrials.gov record NCT03562130 at 2026-11-15T21:55:23.600Z. Its registry update date was 2025-09-11, and PeptideScanner's reviewed identity mapping was teduglutide.↗

  3. Literature metadata

    Teduglutide treatment during breast feeding in a patient with intestinal failure: a case report.↗

    PubMed lists PMID 40771220 in Frontiers in nutrition as Case Reports, Journal Article, with publication-date metadata of 2025-07-23 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  4. Literature metadata

    Short bowel syndrome and d-lactic acidosis: A case report with supplemental home parenteral nutrition and teduglutide.↗

    PubMed lists PMID 40086997 in Endocrinologia, diabetes y nutricion as Case Reports, Journal Article, Review, with publication-date metadata of 2025-03 (month precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  5. Clinical trials

    ClinicalTrials.gov record NCT02949362↗

    PeptideScanner retained ClinicalTrials.gov record NCT02949362 at 2026-11-15T21:55:23.600Z. Its registry update date was 2025-03-19, and PeptideScanner's reviewed identity mapping was teduglutide.↗

  6. Literature metadata

    Baseline Characteristics of Adult Patients Treated and Never Treated with Teduglutide in a Multinational Short Bowel Syndrome and Intestinal Failure Registry.↗

    PubMed lists PMID 39125394 in Nutrients as Journal Article, Multicenter Study, Observational Study, with publication-date metadata of 2024-08-01 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2024

3 records
  1. Literature metadata

    Management Patterns of Teduglutide Use in Short Bowel Syndrome: A Survey of 70 Healthcare Professionals.↗

    PubMed lists PMID 39519595 in Nutrients as Journal Article, with publication-date metadata of 2024-11-01 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Regulatory

    Federal Register notice 2024-16618↗

    The Federal Register published notice 2024-16618, attributed to FDA and its parent HHS department, on 2024-07-29. Its official title is “Pediatric Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments,” and PeptideScanner's exact reviewed identity mapping connects the document to Teduglutide.↗

  3. Clinical trials

    ClinicalTrials.gov record NCT05027308↗

    PeptideScanner retained ClinicalTrials.gov record NCT05027308 at 2026-11-15T21:55:23.600Z. Its registry update date was 2024-05-16, and PeptideScanner's reviewed identity mapping was teduglutide.↗

Source year

2023

6 records
  1. Clinical trials

    ClinicalTrials.gov record NCT04290429↗

    PeptideScanner retained ClinicalTrials.gov record NCT04290429 at 2026-11-15T21:55:23.600Z. Its registry update date was 2023-11-29, and PeptideScanner's reviewed identity mapping was teduglutide.↗

  2. Literature metadata

    Expression, Purification and Characterization of Functional Teduglutide Using GST Fusion System in Prokaryotic Cells.↗

    PubMed lists PMID 37646058 in Advanced pharmaceutical bulletin as Journal Article, with publication-date metadata of 2022-12-06 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Literature metadata

    Teduglutide for the treatment of short bowel syndrome: a double-edged sword?↗

    PubMed lists PMID 37270286 in The American journal of clinical nutrition as Editorial, Comment, with publication-date metadata of 2023-05-03 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  4. Literature metadata

    Long-term treatment with teduglutide: a 48-week open-label single-center clinical trial in children with short bowel syndrome.↗

    PubMed lists PMID 37270289 in The American journal of clinical nutrition as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023-05-03 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  5. Clinical trials

    ClinicalTrials.gov record NCT02431325↗

    PeptideScanner retained ClinicalTrials.gov record NCT02431325 at 2026-11-15T21:55:23.600Z. Its registry update date was 2023-06-12, and PeptideScanner's reviewed identity mapping was teduglutide.↗

  6. Clinical trials

    ClinicalTrials.gov record NCT03596164↗

    PeptideScanner retained ClinicalTrials.gov record NCT03596164 at 2026-11-15T21:55:23.600Z. Its registry update date was 2023-03-15, and PeptideScanner's reviewed identity mapping was teduglutide.↗

Source year

2022

6 records
  1. Clinical trials

    ClinicalTrials.gov record NCT04465396↗

    PeptideScanner retained ClinicalTrials.gov record NCT04465396 at 2026-11-15T21:55:23.600Z. Its registry update date was 2022-10-04, and PeptideScanner's reviewed identity mapping was teduglutide.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT03422666↗

    PeptideScanner retained ClinicalTrials.gov record NCT03422666 at 2026-11-15T21:55:23.600Z. Its registry update date was 2022-06-14, and PeptideScanner's reviewed identity mapping was teduglutide.↗

  3. Clinical trials

    ClinicalTrials.gov record NCT03442972↗

    PeptideScanner retained ClinicalTrials.gov record NCT03442972 at 2026-11-15T21:55:23.600Z. Its registry update date was 2022-05-25, and PeptideScanner's reviewed identity mapping was teduglutide.↗

  4. Clinical trials

    ClinicalTrials.gov record NCT03268811↗

    PeptideScanner retained ClinicalTrials.gov record NCT03268811 at 2026-11-15T21:55:23.600Z. Its registry update date was 2022-05-24, and PeptideScanner's reviewed identity mapping was teduglutide.↗

  5. Literature metadata

    Hernia enlargement and pancreatitis in a patient with short bowel syndrome treated with teduglutide.↗

    PubMed lists PMID 34903028 in Nutricion hospitalaria as Case Reports, Journal Article, with publication-date metadata of 2022-02-09 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  6. Clinical trials

    ClinicalTrials.gov record NCT02980666↗

    PeptideScanner retained ClinicalTrials.gov record NCT02980666 at 2026-11-15T21:55:23.600Z. Its registry update date was 2022-02-02, and PeptideScanner's reviewed identity mapping was teduglutide.↗

Source year

2021

19 records
  1. Clinical trials

    ClinicalTrials.gov record NCT02889393↗

    PeptideScanner retained ClinicalTrials.gov record NCT02889393 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-10-06, and PeptideScanner's reviewed identity mapping was teduglutide.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT03716115↗

    PeptideScanner retained ClinicalTrials.gov record NCT03716115 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-09-27, and PeptideScanner's reviewed identity mapping was teduglutide.↗

  3. Literature metadata

    Colon polyps in patients with short bowel syndrome before and after teduglutide: Post hoc analysis of the STEPS study series.↗

    PubMed lists PMID 31522784 in Clinical nutrition (Edinburgh, Scotland) as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2019-08-23 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  4. Literature metadata

    Teduglutide Therapy in 2 Patients With Short-Bowel Syndrome and Familial Adenomatous Polyposis.↗

    PubMed lists PMID 32829492 in JPEN. Journal of parenteral and enteral nutrition as Case Reports, Journal Article, with publication-date metadata of 2020-09-07 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  5. Literature metadata

    Comprehensive nutritional assessment in short bowel syndrome with chronic renal failure on teduglutide therapy: A case report.↗

    PubMed lists PMID 32088500 in Nutrition (Burbank, Los Angeles County, Calif.) as Case Reports, Journal Article, with publication-date metadata of 2020-01-07 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  6. Clinical trials

    ClinicalTrials.gov record NCT00930644↗

    PeptideScanner retained ClinicalTrials.gov record NCT00930644 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-06-11, and PeptideScanner's reviewed identity mapping was teduglutide.↗

  7. Clinical trials

    ClinicalTrials.gov record NCT01560403↗

    PeptideScanner retained ClinicalTrials.gov record NCT01560403 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-06-10, and PeptideScanner's reviewed identity mapping was teduglutide.↗

  8. Clinical trials

    ClinicalTrials.gov record NCT00081458↗

    PeptideScanner retained ClinicalTrials.gov record NCT00081458 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-06-09, and PeptideScanner's reviewed identity mapping was teduglutide.↗

  9. Clinical trials

    ClinicalTrials.gov record NCT01952080↗

    PeptideScanner retained ClinicalTrials.gov record NCT01952080 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-06-09, and PeptideScanner's reviewed identity mapping was teduglutide.↗

  10. Clinical trials

    ClinicalTrials.gov record NCT02340819↗

    PeptideScanner retained ClinicalTrials.gov record NCT02340819 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-06-09, and PeptideScanner's reviewed identity mapping was teduglutide.↗

  11. Clinical trials

    ClinicalTrials.gov record NCT01209351↗

    PeptideScanner retained ClinicalTrials.gov record NCT01209351 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-06-04, and PeptideScanner's reviewed identity mapping was teduglutide.↗

  12. Clinical trials

    ClinicalTrials.gov record NCT00798967↗

    PeptideScanner retained ClinicalTrials.gov record NCT00798967 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-06-03, and PeptideScanner's reviewed identity mapping was teduglutide.↗

  13. Clinical trials

    ClinicalTrials.gov record NCT00172185↗

    PeptideScanner retained ClinicalTrials.gov record NCT00172185 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-06-02, and PeptideScanner's reviewed identity mapping was teduglutide.↗

  14. Clinical trials

    ClinicalTrials.gov record NCT00072839↗

    PeptideScanner retained ClinicalTrials.gov record NCT00072839 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-05-25, and PeptideScanner's reviewed identity mapping was teduglutide.↗

  15. Literature metadata

    Experience With Teduglutide in Pediatric Short Bowel Syndrome: First Real-life Data.↗

    PubMed lists PMID 32804906 in Journal of pediatric gastroenterology and nutrition as Journal Article, with publication-date metadata of 2020-12 (month precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  16. Clinical trials

    ClinicalTrials.gov record NCT00308438↗

    PeptideScanner retained ClinicalTrials.gov record NCT00308438 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-05-14, and PeptideScanner's reviewed identity mapping was teduglutide.↗

  17. Clinical trials

    ClinicalTrials.gov record NCT00819468↗

    PeptideScanner retained ClinicalTrials.gov record NCT00819468 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-05-14, and PeptideScanner's reviewed identity mapping was teduglutide.↗

  18. Clinical trials

    ClinicalTrials.gov record NCT03571516↗

    PeptideScanner retained ClinicalTrials.gov record NCT03571516 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-05-11, and PeptideScanner's reviewed identity mapping was teduglutide.↗

  19. Literature metadata

    Enteral Autonomy and Days Off Parenteral Support With Teduglutide Treatment for Short Bowel Syndrome in the STEPS Trials.↗

    PubMed lists PMID 31423614 in JPEN. Journal of parenteral and enteral nutrition as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2019-08-18 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2020

4 records
  1. Literature metadata

    Teduglutide for short bowel syndrome.↗

    PubMed lists PMID 32346219 in Australian prescriber as Journal Article, Review, with publication-date metadata of 2020-03-03 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT03663582↗

    PeptideScanner retained ClinicalTrials.gov record NCT03663582 at 2026-11-15T21:55:23.600Z. Its registry update date was 2020-08-04, and PeptideScanner's reviewed identity mapping was teduglutide.↗

  3. Literature metadata

    Accelerated Colorectal Polyposis in an Immunosuppressed Patient With a Small Bowel Transplant Treated With Teduglutide: Case Report and Review of Literature.↗

    PubMed lists PMID 31176580 in Clinical colorectal cancer as Case Reports, Journal Article, Review, with publication-date metadata of 2019-03-11 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  4. Literature metadata

    Teduglutide in Patients With Active Crohn's Disease and Short Bowel Syndrome.↗

    PubMed lists PMID 30990222 in Inflammatory bowel diseases as Case Reports, Letter, with publication-date metadata of 2019-08-20 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2019

1 record
  1. Literature metadata

    Teduglutide for the Treatment of Short Bowel Syndrome.↗

    PubMed lists PMID 24871569 in The Annals of pharmacotherapy as Review, Journal Article, with publication-date metadata of 2014-05-28 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2018

1 record
  1. Literature metadata

    Patients With Short Bowel on Narcotics During 2 Randomized Trials Have Abdominal Complaints Independent of Teduglutide.↗

    PubMed lists PMID 27507402 in JPEN. Journal of parenteral and enteral nutrition as Clinical Trial, Phase III, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2016-08-09 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2016

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT02099084↗

    PeptideScanner retained ClinicalTrials.gov record NCT02099084 at 2026-11-15T21:55:23.600Z. Its registry update date was 2016-02-22, and PeptideScanner's reviewed identity mapping was teduglutide.↗

Source year

2015

1 record
  1. Regulatory

    Federal Register notice 2015-11000↗

    The Federal Register published notice 2015-11000, attributed to FDA and its parent HHS department, on 2015-05-07. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; GATTEX,” and PeptideScanner's exact reviewed identity mapping connects the document to Teduglutide.↗

Source year

2012

4 records
  1. Regulatory

    Drugs@FDA application NDA203441↗

    The official Drugs@FDA dataset lists original submission 1 for NDA 203441 with status AP dated 2012-12-21, and names teduglutide among the application record's active ingredients.↗

  2. Regulatory

    Federal Register notice 2012-20612↗

    The Federal Register published notice 2012-20612, attributed to FDA and its parent HHS department, on 2012-08-22. Its official title is “Gastrointestinal Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Teduglutide.↗

  3. Clinical trials

    ClinicalTrials.gov record NCT01028768↗

    PeptideScanner retained ClinicalTrials.gov record NCT01028768 at 2026-11-15T21:55:23.600Z. Its registry update date was 2012-05-07, and PeptideScanner's reviewed identity mapping was teduglutide.↗

  4. Clinical trials

    ClinicalTrials.gov record NCT01028924↗

    PeptideScanner retained ClinicalTrials.gov record NCT01028924 at 2026-11-15T21:55:23.600Z. Its registry update date was 2012-05-07, and PeptideScanner's reviewed identity mapping was teduglutide.↗